Related Experiment Video
Updated: Dec 28, 2025
10:51
Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device
Published on: August 30, 2016
23.2K
Therapeutics Targeting the Gut Microbiome: Rigorous Pipelines for Drug Development
Kate A Markey1, Marcel R M van den Brink2, Jonathan U Peled1
1Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.
Cell Host & Microbe
|February 14, 2020
Summary
Restoring the gut microbiome offers potential for disease prevention and treatment. This discussion covers the scientific and clinical hurdles in developing and applying these microbiome restoration strategies.
Area of Science:
- Microbiology
- Gastroenterology
- Biotechnology
Background:
- The gut microbiome plays a crucial role in human health.
- Dysbiosis, an imbalance in the gut microbial community, is linked to various diseases.
- Restoring gut microbial balance is a key therapeutic goal.
Purpose of the Study:
- To review the scientific and clinical challenges associated with gut microbiome restoration.
- To highlight the potential of engineered microbiome-based strategies.
- To discuss the implementation of these strategies in clinical practice.
Main Methods:
- Literature review of current research in microbiome engineering and restoration.
- Analysis of scientific challenges in manipulating microbial communities.
- Examination of clinical hurdles in translating microbiome therapies.
Main Results:
- Engineering the gut microbiome presents complex scientific challenges.
- Clinical implementation requires overcoming regulatory, safety, and efficacy hurdles.
- Successful microbiome restoration strategies are emerging.
Conclusions:
- Gut microbiome restoration is a promising therapeutic avenue.
- Significant scientific and clinical challenges must be addressed for successful implementation.
- Further research and development are needed to fully realize the potential of microbiome-based therapies.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
861
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
861
01:29Inflammatory Bowel Disease IV: Pharmacological Management
387
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
387
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
374
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
374
01:17Drugs for Treatment of Diarrhea-Predominant IBS
549
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
549
01:29Bacterial Flora of the Large Intestine
1.4K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.4K